top of page

Wed, Jan 20

|

ONLINE

Anticoagulation in Nonvalvular Atrial Fibrillation in Patients with Renal Disease

Registration is Closed
See other events
Anticoagulation in Nonvalvular Atrial Fibrillation in Patients with Renal Disease
Anticoagulation in Nonvalvular Atrial Fibrillation in Patients with Renal Disease

Time & Location

Jan 20, 2021, 7:00 p.m. – 9:00 p.m. EST

ONLINE

About the Event

About this Event

CHEP+ Clinical Practice Guidelines Program

Anticoagulation in Nonvalvular Atrial Fibrillation in Patients with Renal Disease

Wed January 20, 2021, • 7:00-9:00 PM ET

Presented by: Dr. Sheldon Tobe MD, FRCPC, MScCH (HPTE), FACP, FAHA

Dr.  Tobe is a specialist in Hypertension and Nephrology, Division of  Nephrology, Sunnybrook Health Sciences Centre, and is the University of  Toronto Postgraduate Fellowship Director – Nephrology. He is a Professor  in the Faculty of Medicine, University of Toronto and Northern Ontario  School of Medicine (NOSM).

LEARNING OBJECTIVES

Upon completion of this case study, participants should be able to:

  • Describe the rationale for anticoagulation of non-valvular atrial fibrillation
  • Describe the effect on outcomes of non-valvular atrial fibrillation with CKD
  • Describe the management of patients with CKD and non-valvular atrial fibrillation

Accreditation: This Group Learning program has been certified by the Canadian College  of Family Physicians for up to 6 Mainpro+ credits for the 2-hour  presentation including a practice reflection survey to be completed at 6  weeks post-session.

Share This Event

bottom of page